Various derivatives of the heterocyclic system 1,12,12a,12b-tetrahydrobis-1,2,4-triazolo[4,3-a :3′,4′-c ]quinoxaline of pharmaceutical interest have been obtained by double site- and regio-selective 1,3-dipolar cycloaddition of arylnitrilimines to quinoxalines. No evidence for the formation of mono-adducts was obtained, at variance with literature reports. Specific studies to establish the exact stereochemistry of the bis-cycloadducts were undertaken.

LAURIA, A., GUARCELLO, A., DATTOLO, G., ALMERICO, A.M. (2008). Bis-1,2,4-triazolo[4,3-a:3',4'-c]quinoxalines of pharmaceutical interest from 1,3-dipolar cycloaddition. TETRAHEDRON LETTERS, 49(11), 1847-1850 [10.1016/j.tetlet.2008.01.047].

Bis-1,2,4-triazolo[4,3-a:3',4'-c]quinoxalines of pharmaceutical interest from 1,3-dipolar cycloaddition

LAURIA, Antonino;GUARCELLO, Annalisa;DATTOLO, Gaetano;ALMERICO, Anna Maria
2008-01-01

Abstract

Various derivatives of the heterocyclic system 1,12,12a,12b-tetrahydrobis-1,2,4-triazolo[4,3-a :3′,4′-c ]quinoxaline of pharmaceutical interest have been obtained by double site- and regio-selective 1,3-dipolar cycloaddition of arylnitrilimines to quinoxalines. No evidence for the formation of mono-adducts was obtained, at variance with literature reports. Specific studies to establish the exact stereochemistry of the bis-cycloadducts were undertaken.
2008
LAURIA, A., GUARCELLO, A., DATTOLO, G., ALMERICO, A.M. (2008). Bis-1,2,4-triazolo[4,3-a:3',4'-c]quinoxalines of pharmaceutical interest from 1,3-dipolar cycloaddition. TETRAHEDRON LETTERS, 49(11), 1847-1850 [10.1016/j.tetlet.2008.01.047].
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0040403908000853-main.pdf

Solo gestori archvio

Descrizione: pdf
Dimensione 111.19 kB
Formato Adobe PDF
111.19 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/43930
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact